In 2007, Liron Elia hears a story about a critically ill patient who receives successful medical treatment but later loses his life to pneumonia, an ICU-acquired complication.
This needless death does not make sense to Liron. So he opens medical books and starts studying. His background in computing and mathematics paired with the newly gained medical knowledge enables him to design the initial solution and to submit a patent. In 2008, Liron founds ART MEDICAL.
Fast forward a decade, ART MEDICAL has registered numerous patents, successfully validated its products, and received CE Mark and FDA clearance. And it stays true to the mission that Liron set in 2008 – to bring critical care into the 21st century and save lives through technological innovations.
Medical Advisory Board
Prof. Singer is currently Director of the General Intensive Care Department, Rabin Medical Center, Beilinson Campus, Petach Tikva, Israel, Full Professor of Anesthesia and Intensive Care at the Sackler School of Medicine, Tel Aviv University, Head of the Institute of Nutrition Research at Rabin Medical Center, Chair of the Eduarda and Dr. Moshe Ishay Institute for the Study of the Effects of Natural Food on the Quality of Life and Human Health at the Tel Aviv University, and director of the Metabolism Laboratory at the Felsenstein Medical Research Center.
Dr. Singer was President (2003), Treasurer (2004-2008) and Chairman of the European Society for Clinical Nutrition and Metabolism (ESPEN) (2010-2014) and the co-chairman of the ESPEN Guidelines editorial board (2014-2018). He is an honorary member of ESPEN.
Dr. Grunwald serves as the Executive Director of the Jefferson Israel Center, Thomas Jefferson University (TJU) and Jefferson Health. He has over 38 years of experience in the medical field and served as the chair of the department of anesthesiology for 16 years.
Recently he launched two successful pilot programs with the Israel Innovation Authority (IIA) for Israeli startup companies to test their products at Jefferson. He led the anesthesia for the first liver transplantations at the Hospital of The University of Pennsylvania, the Children’s Hospital of Philadelphia, Hadassah Medical Center, Jerusalem and the Rabin Medical Center, Petah Tikva. Prof. Grunwald is the leading world authority in the perioperative management of patients with Fibrodysplasia Ossificans Progressiva.